Cardiovascular disease risk assessment and reduction: summary of updated NICE guidance

What you need to knowManage cardiovascular disease (CVD) risk using an individualised approach, with lifestyle modification as the first stepFor people without CVD, assess 10 year risk of a CVD event using QRISK3. This can be done as part of NHS health checks and for people likely to be at high risk based on data available in primary care health recordsTools that estimate the lifetime risk of CVD can be valuable to inform discussions and motivate lifestyle changes, especially in people who have modifiable CVD risk factors but a QRISK3 score less than 10% or age under 40Statin therapy is highly cost effective for the primary and secondary prevention of CVD events at all levels of CVD risk, and recommended doses are atorvastatin 20 mg for primary prevention and atorvastatin 80 mg for secondary preventionCardiovascular disease (CVD) is the leading cause of death worldwide, with dyslipidaemia being a highly modifiable…
Read Original Article: Cardiovascular disease risk assessment and reduction: summary of updated NICE guidance »